Finerenone
APICAS: 1050477-31-0
Sample Stock:
Finerenone is a prescription medication used to protect the heart and kidneys in adults with chronic kidney disease (CKD) associated with type 2 diabetes. It represents a significant advancement in treatment for these interconnected conditions.
Related Information
Purity:99%+
Registration:GMP/DMF
Biological Profile
Biological Targets
NR3C2
Associated Conditions
diabetic nephropathy·chronic kidney disease·type 2 diabetes mellitus·cardiovascular disease·heart failure
Key Intermediates
9 Items| Structure | Name | CAS No. | Sample Stock | MDL No. | Details |
|---|---|---|---|---|---|
 | 4-Amino-5-methylpyridin-2(1H)-one | 95306-64-2 | MFCD12546373 | ||
 | 2-Cyanoethyl 3-oxobutanoate | 65193-87-5 | MFCD24687999 | ||
 | 2-Chloro-5-methylpyridin-4-amine | 79055-62-2 | MFCD11977435 | ||
 | 4-Formyl-3-methoxybenzonitrile | 21962-45-8 | MFCD07779491 | ||
 | 2-Cyanoethyl 2-(4-cyano-2-methoxybenzylidene)-3-oxobutanoate | 1050477-39-8 | - | ||
 | 2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate | 1050477-43-4 | MFCD32205331 | ||
 | 2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate | 1050477-44-5 | MFCD32204862 | ||
 | 4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxylic acid | 1050477-45-6 | MFCD32205587 | ||
 | 4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide | 1050477-27-4 | - |